Background: There is a worldwide over-prescription of inhaled corticosteroids (ICS) in
patients with chronic obstructive pulmonary disease (COPD), off-label prescribing, and …

Purpose Inhaled corticosteroids (ICS) are frequently used to treat chronic obstructive
pulmonary disease (COPD) outside the current recommendations. Our aim was to describe …

Introduction Identifying the variables that guide decision-making in relation to the use of
inhaled corticosteroids (ICS) can contribute to the appropriate use of these drugs. The …

In a primary care setting, our aim was to investigate characteristics of patients classified as
having chronic obstructive pulmonary disease (COPD) and currently being prescribed …

Inhaled corticosteroids (ICS) for COPD have been much debated. Our aim was to investigate
characteristics of ICS prescribed COPD patients managed only in general practice …

Background and Objective Inhaled corticosteroids (ICS) for COPD has been much debated.
Our aim was to identify characteristics associated with prescribing ICS for patients with …

Purpose Inhaled corticosteroids (ICS) are often more widely prescribed in the treatment of
chronic obstructive pulmonary disease (COPD) than what is recommended in the …

Background Inhaled corticosteroids (ICS) are a prevailing treatment option for COPD
patients but recent guidelines have relegated their use predominantly to patients with …

Despite the fact that the recommendations of the main clinical guidelines have restricted the
indications for inhaled corticosteroids in chronic obstructive pulmonary disease (COPD) …

Inhaled corticosteroid (ICS) use in chronic obstructive pulmonary disease (COPD) patients is
associated with a reduction of exacerbations and a potential risk of pneumonia. The …